MM

Meena Mishra

Active Director Director DIN 08825388
DIN 08825388 First appointment Aug 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2020
Shareholding value •••• Premium profile

About Meena Mishra

Data last updated:

Meena Mishra is a Director at Oryzer Biotec Private Limited (since 2020). The company operates in Pharma. Oryzer Biotec Private Limited reported revenue of ₹25.3 Lakh (FY 2025).

DIN 08825388
Primary Designation Director
Industry Pharma
First Appointment 07 Aug 2020
Oldest Company Age 11 yrs
Largest company Oryzer Biotec Private Limited · ₹25.3 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Oryzer Biotec Private Limited U74140DL2015PTC285934
Director07 Aug 20202015₹25.3 Lakh (FY 2025)Active

Board colleagues of Meena Mishra

NameDINCompanyDesignation
Dharmendra Kumar Tiwari08246024Oryzer Biotec Private LimitedDirector

Directorship timeline

Open interactive timeline →
Oryzer Biotec Private Limited
Premium access

Shareholding and investment profile for Meena Mishra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Meena Mishra

Meena Mishra currently holds 1 directorship: Oryzer Biotec Private Limited (Director, since 07 Aug 2020, revenue ₹25.3 Lakh (FY 2025)).

Meena Mishra was first appointed on 07 Aug 2020 as Director at Oryzer Biotec Private Limited.

The current boards of Meena Mishra's companies include Dharmendra Kumar Tiwari (Oryzer Biotec Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available